A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses.

Molecular and Cellular Biology
F KohlhuberI M Kerr

Abstract

Cell lines that are mutated in interferon (IFN) responses have been critical in establishing an essential role for the JAK family of nonreceptor tyrosine kinases in interferon signalling. Mutant gamma1A cells have previously been shown to be complemented by overexpression of JAK2. Here, it is shown that these cells carry a defect in, and can also be complemented by, the beta-subunit of the IFN-gamma receptor, consistent with the hypothesis that the mutation in these cells affects JAK2-receptor association. In contrast, mutant gamma2A cells lack detectable JAK2 mRNA and protein. By using gamma2A cells, the role of various domains and conserved tyrosine residues of JAK2 in IFN-gamma signalling was examined. Individual mutation of six conserved tyrosine residues, mutation of a potential phosphatase binding site, or mutation of the arginine residue in the proposed SH2-like domain had no apparent effect on signalling in response to IFN-gamma. Results with deletion mutants, however, indicated that association of JAK2 with the IFN-gammaR2 subunit requires the amino-terminal region but not the pseudokinase domain. Consistent with this, in chimeras with JAK1, the JAK2 amino-terminal region was required for receptor association and STAT1...Continue Reading

References

Aug 25, 1992·Proceedings of the National Academy of Sciences of the United States of America·C SchindlerJ E Darnell
Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M MurakamiT Kishimoto
Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·R McKendryG R Stark
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J F Bazan
Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A F Wilks
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·L E ReidI M Kerr
Jun 16, 1995·The Journal of Biological Chemistry·S J FrankA S Kraft
Sep 8, 1995·The Journal of Biological Chemistry·S V KotenkoJ N Ihle
Mar 24, 1995·The Journal of Biological Chemistry·J W TannerA S Shaw
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·O SilvennoinenJ N Ihle
Jan 5, 1996·The Journal of Biological Chemistry·D H KaplanR D Schreiber
Mar 8, 1996·The Journal of Biological Chemistry·Y HanG R Stark
Jun 1, 1996·Molecular and Cellular Biology·E A BachR D Schreiber
Jul 19, 1996·The Journal of Biological Chemistry·S V KotenkoS Pestka

❮ Previous
Next ❯

Citations

Dec 3, 2005·Leukemia & Lymphoma·Maria E Nelson, David P Steensma
Feb 22, 2012·Growth Factors·Hiu Kiu, Sandra E Nicholson
Sep 6, 2011·The EMBO Journal·Judith StaerkStefan N Constantinescu
Nov 17, 2009·Biochemical and Biophysical Research Communications·Ning YangStuart J Frank
Jun 6, 2006·Biochemical Pharmacology·Claude HaanIris Behrmann
Nov 9, 2004·Biochemical and Biophysical Research Communications·Tadashi MatsudaJames N Ihle
Aug 30, 2008·Seminars in Cell & Developmental Biology·Andrew F Wilks
Jul 31, 2014·Biochemical Pharmacology·Yu-Fon ChenTian-Shung Wu
Nov 21, 2012·PloS One·Tobias Nespital, Ger J Strous
Jun 11, 2015·PloS One·Francesca Isabella De-SimoneIlker Kudret Sariyer
Oct 5, 2013·BMC Cancer·Yong TengJohn K Cowell
May 23, 1998·Annual Review of Immunology·W J Leonard, J J O'Shea
Oct 6, 1998·Annual Review of Biochemistry·G R StarkR D Schreiber
Oct 31, 2016·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Kun WuXu Liu
Jan 30, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jean-Philippe DefourStefan N Constantinescu
Jul 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·T C YehS Pellegrini
Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·M C GauzziS Pellegrini
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·D W LeamanG R Stark
Jan 28, 1999·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·C A Bonjardim
Oct 16, 2007·Oncogene·S J BakerE P Reddy
May 7, 2014·Nature Structural & Molecular Biology·Randall McNally, Michael J Eck
Nov 29, 2002·Protein Engineering·Fabrizio Giordanetto, Romano T Kroemer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.